Drugs / Dendrobium Huoshanense Suppository
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05079438 | Sep 2021 → Jul 2023 | — | Zhejiang Cancer Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dendrobium Huoshanense Suppository | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05079438 ↗ |
| Route | Rectal | “1.7g rectal administration per day for 5 weeks” NCT05079438 ↗ |